Stupp R, Tonn J-C, Brada M, Pentheroudakis G (2010) High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annal of Oncology 21:v190–v193. https://doi.org/10.1093/annonc/mdq187

Dolocek TA, Propp JM, Stroup NE et al (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(Suppl 5):1–49

Article  Google Scholar 

Wem PY, Kesari S (2008) Malignant gliomas in adults. New England Med 359:492–507

Article  Google Scholar 

Sherriff J, Tamangani J, Senthil L, Cruickshank G, Spooner D, Jones B et al (2013) Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide. Br J Radiol 86:20120414

CAS  Article  Google Scholar 

Pichlmeier U, Bink A, Schackert G et al (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncology 10:1025–1034

Article  Google Scholar 

Studio R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5 year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466

Dirks P, Bernstein M, Muller PJ, Tucker WS (1993) The value of re-operation for recurrent glioblastoma. Can J Surg 36:271–275

CAS  PubMed  Google Scholar 

Barbagallo GM, Jenkinson MD, Brodbelt AR (2008) ”Recurrent” glioblastoma multiforme, when should we reoperate? Br J Neurosurg 22:452–455

Perry JR et al (2010) Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study. Clin Oncol 28(12):2051–2057

Meryem Aktan M, Koc, Gul Kanyilmaz (2015) Survival following re-irradiation using intensity-modulated radiaton therapy with temozolomide in selected patients with recurrent high grade gliomas. Ann Transl Med 3(20):304. https://doi.org/10.3978/j.issn.2305-5839.2015.11.29

CAS  Article  PubMed  PubMed Central  Google Scholar 

Wang 13X, Guo G, Guan H, Yu Y, Lu J, Jinming Yu (2019) Challenges and potential of PD-1/PD-L1checkpoint blockade immunotherapy for glioblastoma. J Exp Clin Cancer Res 38:87. https://doi.org/10.1186/s13046-019-1085-3

Phuphanich S, Wheeler CJ, Rudnick JD, Mazer M, Wang H, Nuño MA et al (2013) Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma. Cancer Immunol Immunother 62:125–135

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS et al (2018) First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma. J Transl Med 16:142

CAS  Article  Google Scholar 

Jain KK (2018) Critical overview of targeted therapies for glioblastoma. Front Oncol 8:419

Article  Google Scholar 

Taunk NK, Moraes FY, Escorcia FE, Mendez LC, Beal K, Marta GN (2016) External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma. Expert Rev Anticancer Ther 16(3):347–358

Amichetti M, Amelio D (2011) A Review of the role of the Re-irradiation in recurrent high-grade glioma (HGG). Cancers (Basel) 3:4061–4089

Article  Google Scholar 

Kazmi F, Soon YY, Leong Y, Koh WY, Vellayappan B (2018) Re-irradiation for recurrent glioblastoma (GBM) a systematic review and meta-analyis. Journal of Neuro-Oncology 142(1):79–90

Minniti G, Scaringi C, De Sanctis V, Lanzetta G, Falco T, Di Stefano D et al (2013) Hypofractionated stereotactic radiotherapy and continuous low- dose temozolomide in patients with recurrent or progressive malignant gliomas. J Neurooncol 111:187–194

CAS  Article  Google Scholar 

Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R et al (2005) Re-irradiation of recurrent high- grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys 63:511–519.24

CAS  Article  Google Scholar 

Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G (2007) Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma. J Neurooncol 81:287–294.25

Article  Google Scholar 

Wuthrick EJ, Curran WJ, Camphausen K, Lin A, Glass J, Evans J et al (2014) A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high- grade glioma. Int J Radiat Oncol Biol Phys 90:369–375.26

CAS  Article  Google Scholar 

Patel M, Siddiqui F, Jin J-Y, Mikkelsen T, Rosenblum M, Movsas B et al (2009) Salvage re-irradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neurooncol 92:185–191

Article  Google Scholar 

Bratengeier K, Oechsner M, Gainey M, Flentje M (2009) Remarks on reporting and recording consistent with the ICRU reference dose. Radiat Oncol 4:44. https://doi.org/10.1186/1748-717X-4-44

CAS  Article  PubMed  PubMed Central  Google Scholar 

Lin NU, Lee EQ et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncology 16:e270–e278

Article  Google Scholar 

Straube C, Elpula G, Gempt J, Gerhardt J, Bette S, Zimmer C, Schmidt-Graf F, Meyer B, Combs SE (2017) Re-irradiation after gross total resection of recurrent glioblastoma. Strahlenther Onkol. https://doi.org/10.1007/s00066-017-1161-6

Article  PubMed  Google Scholar 

Fokas E, Wacker U, Gross MW, Henzel M, Encheva E, Engenhart- Cabillic R (2009) Hypofractionated stereotactic re-irradiation of recurrent glioblastomas. Strahlenther Onkol 185:235–240. https://doi.org/10.1007/s00066-009-1753-x

Article  PubMed  Google Scholar 

Niyazi M, Siefert A, Schwarz SB et al (2011) Therapeutic options for recurrent malignant glioma. Radiother Oncol 98:1–14

Article  Google Scholar 

Amelio D, Amichetti M (2012) Radiation therapy for the treatment of recurrent glioblastoma: an overview. Cancers (Basel) 4:257–280

Article  Google Scholar 

Redmond KJ, Mehta M (2015) Stereotactic radiosurgery for glioblastoma. Cureus 7:e413

PubMed  PubMed Central  Google Scholar 

Fogh SE, Andrews DW, Glass J et al (2010) Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol 28:3048–3053

Article  Google Scholar 

Chatzikonstantinou G, Zamboglou N, Archavlis E, Strouthos I, Zoga E, Milickovic N, Hilaris B, Baltas D, Rödel C, Tselis N. (2018) CT-guided interstitial HDR-brachytherapy for recurrent glioblastoma multiforme: a 20-year single-institute experience Strahlenther Onkol. 194(12):1171–1179. https://doi.org/10.1007/s00066-018-1358-3

Combs SE, Niyazi M, Adeberg S, Bougatf N, Kaul D et al (2018) Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score—report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK). Cancer Med 7(5): 1742–1749

Krauze AV, Peters C, Cheng J et al (2017) Re-irradiation for recurrent glioma- the NCI experience in tumor control, OAR toxicity and proposal of a novel prognostic scoring system. Radiat Oncol Lond Engl 12(1):191. https://doi.org/10.1186/s13014-017-0930-9

Article  Google Scholar 

Zwirner K, Paulsen F, Schittenhelm J et al (2017) Prognostic parameters and outcome after re-irradiation for progressive glioblastoma. Acta Neurol Scand 136:239–245

CAS  Article  Google Scholar 

Klobukowski L, Falkov A, Chelimo C et al (2018) A retrospective review of re-irradiating patients’ recurrent high-grade gliomas. Clin Oncol (R Coll Radiol) 30:563–570

CAS  Article  Google Scholar 

Post CCB, Kramer MCA, Smid EJ et al (2019) Patterns of re-irradiation for recurrent gliomas and validation of a prognostic score. Radiother Oncol 130:156–163

Shi W, Scannell Bryan M, Gilbert MR, Mehta MP, Blumenthal DT, Brown PD, Valeinis E, Hopkins K, Souhami L, Andrews DW, Tzuk-Shina T, Howard SP, Youssef EF, Lessard N, Dignam JJ, Werner-Wasik M (2017) Investigating the effect of reirradiation or systemic therapy in patients with glioblastoma after tumor progression: a secondary analysis of NRG oncology/radiation therapy oncology group trial 0525. Int J Radiat Oncol Biol Phys 100:38–44. https://doi.org/10.1016/j.ijrobp.2017.08.038

Combs SE, Edler L, Rausch R, Welzel T, Wick W, Debus J (2013) Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma. Acta Oncol 52:147–152. https://doi.org/10.3109/0284186X.2012.692882

Article  PubMed  Google Scholar 

Kessel KA, Hesse J, Straube C, Zimmer C, Schmidt-Graf F, Schlegel J, Meyer B, Combs SE (2017) Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma. PLoS ONE 12:e0180457. https://doi.org/10.1371/journal.pone.0180457

Kim IH (2019) Appraisal of re-irradiation for the recurrent glioblastoma in the era of MGMT promotor methylation. Radiat Oncol J 37(1):1–12. https://doi.org/10.3857/roj.2019.00171T

Article  PubMed  PubMed Central  Google Scholar 

Tunthanathip T, Ratanalert S, Sae-heng S, Oearsakul T, Sakaruncchai I, Kaewborisutsakul A, Chotsampancharoen T, Intusoma U, Kitkhuandee A, Vaniyapong T (2020) Prognostic Factors and Nomogram Predicting Survival in Diffuse Astrocytoma. J Neurosci Rural Pract 11(1):135–143. https://doi.org/10.1055/s-0039-3403446

Article  PubMed  PubMed Central  Google Scholar 

Guyotat J, Signorelli F, Frappaz D, Madarassy G, Ricci AC, Bret P (2000) Is re-operation for recurrence of glioblastoma justified? Oncol Rep 7:899–904